Eurepa-V 1/0.2 Tablet
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Repaglinide (1mg) + Voglibose (0.2mg)
Overview Eurepa-V 1/0.2 Tablet
DiaBeta Duo 1/0.2mg tablets combine two medications to manage type 2 diabetes. This treatment helps regulate post-prandial hyperglycemia (high blood sugar after meals) when dietary changes and other similar therapies prove insufficient. Take DiaBeta Duo immediately following meals, as prescribed by your physician. Discontinuing this medication without consulting your doctor can lead to elevated blood sugar, potentially causing serious complications such as renal impairment and vision loss. If you miss a dose, avoid taking it between meals; administer it with your next meal. Never double the dose. This medication complements a comprehensive diabetes management plan, including diet, exercise, and weight control, as directed by your doctor. Common, usually temporary side effects include gas, diarrhea, abdominal discomfort, hypoglycemia, and skin reactions. Persistent or concerning side effects warrant immediate medical attention. Regular blood glucose monitoring is essential. Prior to use, disclose any kidney or liver conditions, urinary tract infections, diuretic use, or pregnancy/breastfeeding to your doctor. Limit alcohol consumption to minimize potential side effect risk.
Uses of Eurepa-V 1/0.2 Tablet
Managing Type 2 Diabetes
Major Benefits of Eurepa-V 1/0.2 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Eurepa-V 1/0.2 Tablets should be administered with a meal.
Common Side effects of Eurepa-V 1/0.2 Tablet:
- Hypoglycemia (low blood glucose level)
- Abdominal pain
- Diarrhea
- Flatulence
- Headache
How to use Eurepa-V 1/0.2 Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Eurepa-V 1/0.2 Tablet with a meal.
How Eurepa-V 1/0.2 Tablet works:
Diabetic medication Eurepa-V, available in 1/0.2mg tablets, combines two antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Eurepa-V 1/0.2 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Eurepa-V 1/0.2 Tablet during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Eurepa-V 1/0.2 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
For individuals with severe kidney impairment, Eurepa-V 1/0.2 Tablet requires careful administration. Dosage modification of Eurepa-V 1/0.2 Tablet may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Eurepa-V 1/0.2 Tablet cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Eurepa-V 1/0.2 Tablet :
Should you forget to take a Eurepa-V 1/0.2 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Eurepa-V 1/0.2 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently